Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.722
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Wiley